![PDF] Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study | Semantic Scholar PDF] Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9207875f6890d78fbc50dc3e62d148c29ea5634f/4-Figure2-1.png)
PDF] Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study | Semantic Scholar
![PDF) A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil PDF) A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil](https://i1.rgstatic.net/publication/369313448_A_case_of_aromatase_inhibitor-induced_alopecia_successfully_treated_with_low-dose_oral_minoxidil/links/64639675db66756cda6bac28/largepreview.png)
PDF) A case of aromatase inhibitor‐induced alopecia successfully treated with low‐dose oral minoxidil
Several studies in the past have reported the benefits of topical and oral minoxidil in treating traction alopecia (TA). Other treatments… | Instagram
![Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research](https://onlinelibrary.wiley.com/cms/asset/aad32a7a-6b54-455c-aeba-1c808c4231db/srt12827-fig-0001-m.jpg)
Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research
![Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology](https://onlinelibrary.wiley.com/cms/asset/fec1e2e8-1746-4367-ab4d-0b1d79098e29/jdv17623-fig-0001-m.jpg)
Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial - Bokhari - 2022 - Journal of the European Academy of Dermatology
![A, A 30-year-old man with androgenetic alopecia. B, Initial clinical... | Download Scientific Diagram A, A 30-year-old man with androgenetic alopecia. B, Initial clinical... | Download Scientific Diagram](https://www.researchgate.net/publication/335764203/figure/fig1/AS:865808767000576@1583436304171/A-A-30-year-old-man-with-androgenetic-alopecia-B-Initial-clinical-response-after-4.jpg)